BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22605564)

  • 1. Cysteine racemization during the Fmoc solid phase peptide synthesis of the Nav1.7-selective peptide--protoxin II.
    Park JH; Carlin KP; Wu G; Ilyin VI; Kyle DJ
    J Pept Sci; 2012 Jul; 18(7):442-8. PubMed ID: 22605564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies examining the relationship between the chemical structure of protoxin II and its activity on voltage gated sodium channels.
    Park JH; Carlin KP; Wu G; Ilyin VI; Musza LL; Blake PR; Kyle DJ
    J Med Chem; 2014 Aug; 57(15):6623-31. PubMed ID: 25026046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin.
    Xu H; Li T; Rohou A; Arthur CP; Tzakoniati F; Wong E; Estevez A; Kugel C; Franke Y; Chen J; Ciferri C; Hackos DH; Koth CM; Payandeh J
    Cell; 2019 Feb; 176(4):702-715.e14. PubMed ID: 30661758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Disulfide Bond Replacements in Analogues of the Tarantula Toxin ProTx-II and Their Effects on Inhibition of the Voltage-Gated Sodium Ion Channel Na
    Wright ZVF; McCarthy S; Dickman R; Reyes FE; Sanchez-Martinez S; Cryar A; Kilford I; Hall A; Takle AK; Topf M; Gonen T; Thalassinos K; Tabor AB
    J Am Chem Soc; 2017 Sep; 139(37):13063-13075. PubMed ID: 28880078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of ProTx-I and the novel venom peptide Pe1b provide insight into residues responsible for selective inhibition of the analgesic drug target Na
    Rupasinghe DB; Herzig V; Vetter I; Dekan Z; Gilchrist J; Bosmans F; Alewood PF; Lewis RJ; King GF
    Biochem Pharmacol; 2020 Nov; 181():114080. PubMed ID: 32511987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ProTx-I and ProTx-II: gating modifiers of voltage-gated sodium channels.
    Priest BT; Blumenthal KM; Smith JJ; Warren VA; Smith MM
    Toxicon; 2007 Feb; 49(2):194-201. PubMed ID: 17087985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spider-venom peptides that target voltage-gated sodium channels: pharmacological tools and potential therapeutic leads.
    Klint JK; Senff S; Rupasinghe DB; Er SY; Herzig V; Nicholson GM; King GF
    Toxicon; 2012 Sep; 60(4):478-91. PubMed ID: 22543187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1.
    Murray JK; Long J; Zou A; Ligutti J; Andrews KL; Poppe L; Biswas K; Moyer BD; McDonough SI; Miranda LP
    J Med Chem; 2016 Mar; 59(6):2704-17. PubMed ID: 26890998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of sodium channel gating by trapping the domain II voltage sensor with protoxin II.
    Sokolov S; Kraus RL; Scheuer T; Catterall WA
    Mol Pharmacol; 2008 Mar; 73(3):1020-8. PubMed ID: 18156314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant production, bioconjugation and membrane binding studies ofPn3a, a selective Na
    Sharma G; Deuis JR; Jia X; Mueller A; Vetter I; Mobli M
    Biochem Pharmacol; 2020 Nov; 181():114148. PubMed ID: 32663452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency-Enhancing Mutations of Gating Modifier Toxins for the Voltage-Gated Sodium Channel Na
    Katz D; Sindhikara D; DiMattia M; Leffler AE
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33800031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three Peptide Modulators of the Human Voltage-Gated Sodium Channel 1.7, an Important Analgesic Target, from the Venom of an Australian Tarantula.
    Chow CY; Cristofori-Armstrong B; Undheim EA; King GF; Rash LD
    Toxins (Basel); 2015 Jun; 7(7):2494-513. PubMed ID: 26134258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Na
    Adams GL; Pall PS; Grauer SM; Zhou X; Ballard JE; Vavrek M; Kraus RL; Morissette P; Li N; Colarusso S; Bianchi E; Palani A; Klein R; John CT; Wang D; Tudor M; Nolting AF; Biba M; Nowak T; Makarov AA; Reibarkh M; Buevich AV; Zhong W; Regalado EL; Wang X; Gao Q; Shahripour A; Zhu Y; de Simone D; Frattarelli T; Pasquini NM; Magotti P; Iaccarino R; Li Y; Solly K; Lee KJ; Wang W; Chen F; Zeng H; Wang J; Regan H; Amin RP; Regan CP; Burgey CS; Henze DA; Sun C; Tellers DM
    J Med Chem; 2022 Jan; 65(1):485-496. PubMed ID: 34931831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biophysical, and biological studies of wild-type and mutant psalmopeotoxins--anti-malarial cysteine knot peptides from Psalmopoeus cambridgei.
    Kamolkijkarn P; Prasertdee T; Netirojjanakul C; Sarnpitak P; Ruchirawat S; Deechongkit S
    Peptides; 2010 Apr; 31(4):533-40. PubMed ID: 20067814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Photocrosslinking Probes Based on Huwentoxin-IV to Map the Site of Interaction on Nav1.7.
    Tzakoniati F; Xu H; Li T; Garcia N; Kugel C; Payandeh J; Koth CM; Tate EW
    Cell Chem Biol; 2020 Mar; 27(3):306-313.e4. PubMed ID: 31732432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational Engineering Defines a Molecular Switch That Is Essential for Activity of Spider-Venom Peptides against the Analgesics Target NaV1.7.
    Klint JK; Chin YK; Mobli M
    Mol Pharmacol; 2015 Dec; 88(6):1002-10. PubMed ID: 26429937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical Synthesis, Proper Folding, Na
    Nicolas S; Zoukimian C; Bosmans F; Montnach J; Diochot S; Cuypers E; De Waard S; BĂ©roud R; Mebs D; Craik D; Boturyn D; Lazdunski M; Tytgat J; De Waard M
    Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31234412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side-chain anchoring strategy for solid-phase synthesis of peptide acids with C-terminal cysteine.
    Barany G; Han Y; Hargittai B; Liu RQ; Varkey JT
    Biopolymers; 2003; 71(6):652-66. PubMed ID: 14991675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure and functional characterization of jingzhaotoxin-XI: a novel gating modifier of both potassium and sodium channels.
    Liao Z; Yuan C; Deng M; Li J; Chen J; Yang Y; Hu W; Liang S
    Biochemistry; 2006 Dec; 45(51):15591-600. PubMed ID: 17176080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-Methoxybenzyloxymethyl group, a racemization-resistant protecting group for cysteine in Fmoc solid phase peptide synthesis.
    Hibino H; Nishiuchi Y
    Org Lett; 2012 Apr; 14(7):1926-9. PubMed ID: 22452360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.